Adjuvanted influenza vaccine for the Italian elderly in the 2018/19 season: an updated health technology assessment
ConclusionsAccording to this HTA, aTIV appeared the vaccine of choice in the elderly. HTA should be reapplied whenever new relevant data become available.
Source: The European Journal of Public Health - Category: General Medicine Source Type: research
More News: General Medicine | Influenza | Influenza Vaccine | International Medicine & Public Health | Italy Health | Medical Ethics | Vaccines